文献速递消化道肿瘤放疗放疗物理与技术

直肠癌VMAT-IMRT中减少纵向颅侧边界的剂量学分析与比较

Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer.
PubMed 文献 · Radiat Oncol · 2018-09-06

本研究回顾性分析10例局部进展期直肠癌患者,比较原始PTV与颅侧方向分别缩减1cm、2cm、3cm的PTV计划,处方总剂量50.4Gy、每日1.8Gy。结果显示骨髓、小肠和腹膜腔的V10-V50及Dmedian在颅侧靶体积每缩减1cm时均可显著降低;腹膜腔V10在缩减3cm时剂量近乎减半;缩减3cm时膀胱Dmedian也显著降低。作者同意现有建议,即在TME和IMRT时代减少直肠癌nCRT的颅侧靶体积。

要点

  • 颅侧靶体积每缩减1cm,骨髓、小肠和腹膜腔的V10-V50及Dmedian均显著降低。
  • 颅侧靶体积缩减3cm时,腹膜腔V10剂量近乎减半。
  • 颅侧靶体积缩减3cm时,膀胱Dmedian也显著降低。

核心结论

  • 考虑TME和IMRT时代极低的复发率、复发分布模式及nCRT相关副作用,作者同意现有建议减少nCRT治疗直肠癌患者的颅侧靶体积。

研究设计与样本

  • 回顾性分析10例局部进展期直肠癌患者,所有患者均按容积旋转调强放疗(VMAT)制定计划。
  • 除原始PTV(PTV0)外,为每例患者定义三个新PTV:颅侧方向分别缩减1cm、2cm和3cm。
  • 每个PTV计划总剂量50.4Gy,每日1.8Gy,通过剂量体积直方图(DVH)分析比较危及器官剂量。

主要发现

  • 骨髓、小肠和腹膜腔的所有临床相关相对剂量参数(V10-V50)及Dmedian在颅侧靶体积每缩减1cm时均可显著降低。
  • 腹膜腔V10在靶体积缩减3cm时剂量近乎减半。
  • 靶体积缩减3cm后,膀胱Dmedian也显著降低。

临床怎么用

  • 作者同意现有建议减少nCRT治疗直肠癌患者的颅侧靶体积。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The cranial border of the target volume (TV) in rectal cancer patients treated with neoadjuvant chemoradiation (nCRT) is mostly defined at the level of L5/S1. However, current studies have shown that relapse cranially of the target volume after neoadjuvant nCRT and surgery is very rare. A reduction of cranial TV margins could be reasonable to reduce toxicity to the organs at risk (OAR). In this study we compared the dose distribution to the OAR for different cranial longitudinal margins using a dose-volume histogram (DVH) analysis. METHODS: Ten patients with loco regional advanced rectal cancer were analysed retrospectively. All patients were planned for Volumetric Arc Therapy Radiation Therapy (VMAT). Next to the original PTV (PTV0), three new planning target volumes (PTV) were defined for each patient: The PTV0 reduced by 1 cm, 2 cm and 3 cm on cranial extension. For each PTV a treatment plan with a total dose of 50.4 Gy with daily doses of 1.8 Gy was calculated. Dose to the OAR were evaluated and compared. RESULTS: For the bone marrow, the small bowel and the peritoneal space all clinically relevant relative dose parameters (V10-V50) as well as the Dmedian could be significantly reduced with every cranial target volume reduction of 1 cm. For V10 of the peritoneal space the dose could be nearly halved with a 3 cm shortened TV. After TV reduction of 3 cm also for the urinary bladder a significant dose reduction of the Dmedian could be achieved. CONCLUSIONS: Considering the very low recurrence rates in the TME and IMRT era, the distribution patterns of these relapses as well as the relevant side effects of nCRT, we would agree with existing recommendations of reduction of the cranial target volume in nCRT treated rectal cancer patients.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Dapper H, Oechsner M, Münch S, et al. Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer. Radiat Oncol. 2018. PMID: 30189877. doi:10.1186/s13014-018-1120-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。